Epidemiological evidence on gene-environment effect of G-protein β-3 subunit C825T polymorphism and sodium on blood pressure in free-living general population is limited. We examined the associations between C825T polymorphism and blood pressure levels, stratified by the sodium variables estimated by 24-h urinary sodium excretion and dietary questionnaire among 1,471 men and women aged 30-74 at a community in Japan. Our a priori hypothesis was that individuals with 825T allele have elevated blood pressure among subjects with high sodium intake. Among the whole group, systolic blood pressure level was +2.2 mmHg (p=0.10) higher in TT than CC genotype after adjustment for sex, age, antihypertensive medication use, body mass index, and alcohol consumption. Such difference was more evident among individuals with low sodium excretion (+4.5 mmHg, p=0.01), low present sodium intake (+3.2 mmHg, p=0.11), and low past sodium intake (+4.8 mmHg, p=0.02). No associations were observed among those with high sodium variables. Our results indicate that G-protein β-3 subunit C825T polymorphism is associated with higher systolic blood pressure levels in a large free-living Japanese population, more specifically in women with low sodium intake. This finding helps to explain part of the discrepancy of the previously reported genetic association among different ethnic groups.
INTRODUCTION
G-protein activates various transmembrane receptors and intracellular signaling systems, and regulates arterial blood pressure (BP) (Siffert, 1998) . Siffert et al. were the first group to describe that C825T (C-to-T substitution at nucleotide 825 in exon 10) polymorphism of the G-protein β-3 subunit (GNB3) gene was associated with hypertension . The same study showed that activation of pertussis toxin-sensitive G-proteins significantly enhanced the TC or TT genotypes of GNB3 compared with the CC genotype. Although C825T polymorphism is considered a candidate gene for salt-sensitive hypertension (Beeks et al, 2004) , it is still uncertain whether the C825T polymorphism affects Na + /H + exchanger. Furthermore, the results from subsequent association studies were inconsistent especially in non-Caucasians (Siffert, 2003) , and there has been limited evidence on the gene-environmental interaction among GNB3
C825T polymorphism, sodium and BP.
The aim of this study was to examine the association between GNB3 polymorphism and BP levels according to sodium intake, estimated by 24-h urine collection and dietary questionnaires, in a free-living population. We thus performed a community-based study of 1,471 Japanese in a general community. Our a priori hypothesis was that individuals with 825T allele of the GNB3 gene have elevated BP levels in response to a high sodium intake, and thus the association between GNB3 polymorphism and BP is more evident among individuals with a high sodium intake than those with a low sodium intake.
MATERIALS AND METHODS

Subjects
Subjects were free-living residents of a farming community of Kyowa, central Japan 
Population surveys
The population surveys were performed annually since 1981. Details of the surveys have been described elsewhere (Iso et al, 1996; . Well-trained medical technicians measured arterial systolic blood pressure (SBP) and fifth-phase diastolic blood pressure (DBP) using standard mercury sphygmomanometers (with 14 cm wide and 51 cm long cuff) on the right arm of quietly seated participants after a period of at least 5-min rest. When SBP was ≥140 mmHg and/or DBP was ≥90 mmHg, the measurement was repeated; the average of two readings was used in the analysis, otherwise the first reading was used. The method of BP measurement was standardized uniformly across the surveys, and BP measurement training for our medical technicians was provided before each annual survey. Hypertension was defined as SBP of ≥140 mmHg and/or DBP of ≥90 mmHg, and/or use of antihypertensive medication. The participants were asked to collect all urine over a 24-hour period between 1996 and 2004 surveys. Subjects who provided urine samples of <500 ml and/or <20 hours, or those with incomplete collections based on records were excluded from the study. At the 2001 survey, all participants were also asked to complete a self-administered dietary questionnaire to estimate present and past sodium intake. Past sodium intake was defined as the intake before the recognition of hypertension for hypertensives, and approximately 10 years before the survey for normotensives. A sodium intake score was calculated by adding one point for each of 10 types of sodium intake questions. Although this scoring system was validated previously (Iso et al, 1996; , it was tested again using the samples of the present study. Age and sex-adjusted mean 24-hour sodium excretion values across quintiles of the present sodium intake score (n=1,471) were 165, 173, 186, 197 and 198 Spearman correlation coefficient between past and present sodium intake scores was 0.60 (p<0.001). Repeatability of the present and past sodium intake scores was also tested previously (Iso et al, 1996; by repeating the questionnaire one to two years apart in a sub-sample of the population (n = 287); the Spearman correlation coefficient was 0.73 for the present sodium intake score (p<0.001), and 0.62 for the past sodium intake score (p<0.001) 
DNA genotyping
GNB3 C825T genotypes were determined by the allele-specific primer-polymerase chain reaction method as described previously (Takarada et al, 2002; Ishiguro et al, 2005) . The designed allele-specific sense primers were TxR-TCTGCGGCATCACGTXCG for the 825C allele and FITC-TCTGCGGCATCACGTXTG for the 825T allele labeled at the 5' end either with fluorescein isothiocyanate (FITC) or with Texas red (TxR), and a 5'
biotin-end-labeled antisense primer (biotin-GAATAGTAGGCGGCCACTGA), in which X represents an artificial mismatch base. For high sensitivity and specificity, we used polymorphic base at the second site from 3' end, and placed an artificial mismatch base next to the polymorphic base, instead of matched base in each primer (Ishiguro et al, 2005) .
Statistical analyses
The analysis of covariance and chi-square test were used to compare sex-specific age-adjusted mean values and proportions of risk characteristics, by Tukey's multiple comparison method. The chi-square test was used to examine whether the genotype distributions differed from that expected from Hardy-Weinberg equilibrium. The relation between genotype and BP levels was adjusted by age, sex, antihypertensive Yamagishi et al., Page 7 medication use (yes or no), body mass index (BMI) and alcohol consumption, and examined by Dunnett's multiple comparison method, with CC group as reference.
Further analysis was performed stratified by the medians of urinary sodium excretion and sodium intake scores. For stratified analyses by the sodium intake/excretion, we further adjusted for the year of urine collection (1996-2000 or 2001-2004) . We used dummy variables for adjustment of sex, antihypertensive medication and the year of urine collection, and continuous variables for other covariates. The interactions between genotype and sex, stratified sodium variables in relation to BP levels were examined using cross-product terms of these variables, i.e., polymorphism (CC, TC, TT) × sex (M or F), polymorphism × sodium intake/excretion (below or beyond the median value). All statistical analyses were performed using SAS version 8.02
software (SAS Institute Inc., Cary, NC). All probability values for statistical tests were two-tailed, and values of p<0.05 were regarded as statistically significant. The frequency of GNB3 genotypes was 24.1% for the CC genotype, 49.9% for the CT genotype, and 25.9% for the TT genotype. The sex-specific frequencies were 23.5%, 51.2%, and 25.3% for men, and 24.6%, 49.2%, and 26.3% for women, respectively.
The genotype distribution was in Hardy-Weinberg equilibrium for men (p=0.92), women (p=0.94), and total subjects (p=1.00). The mean age of the subjects was 60 years for men and 55 years for women. The prevalence of hypertension was 51% for men and 39% for women, and the respective mean values of 24-h urine sodium excretion were 195 mmol and 175 mmol (data not shown in the tables). Table 1 provides sex-specific age-adjusted characteristics according to GNB3
genotype. The mean age of the TT group was lower for women and higher for men than those in other genotypes. The mean SBP and DBP were not different among the genotypes. Similarly, the prevalence of antihypertensive medication use and prevalence of hypertension were not different among the genotypes. The mean present sodium intake score of TT group was higher than that of CC group for women, but not for men. The other variables, i.e. BMI, alcohol intake, urine sodium excretion and past sodium intake score were not statistically different among the genotypes.
The mean values of BP levels adjusted for sex, age, antihypertensive medication use, BMI, and alcohol consumption are shown for each GNB3 genotype (Table 2) . For total subjects, the SBP levels were +2.2 mmHg higher in the TT group than CC group; this difference showed a trend towards significance (p=0.10). Yamagishi et al., Page 9 When we performed further stratification by sodium variables (Table 3) , the SBP difference between CC and TT groups was greater among subjects with lower sodium excretion (+4.5 mmHg, p=0.01) than among those with higher sodium excretion (+0.2 mmHg, p=0.99), and the interaction was statistically significant (p=0.01). The interaction for SBP was less evident among men (p=0.58) than women (p=0.01).
These associations were less evident for DBP. The SBP difference between CC and TT genotypes was greater among subjects with lower present sodium intake (+3.2 mmHg, p=0.11) than those with higher sodium intake (+1.3 mmHg, p=0.62), although the interaction did not reach statistical significance (p=0.66). The associations were less evident for DBP.
When we stratified by past sodium intake score, the SBP difference between CC and TT genotypes was more evident among subjects with lower past sodium intake (+4.8 mmHg, p=0.02) than those with higher past sodium intake (+0.2 mmHg, p=0.99) although the interaction did not reach statistical significance (p=0.12). Such a trend was not observed for DBP.
The associations between GNB3 genotypes and BP levels became weaker when restricting subjects without antihypertensive medication (n=1,146); the mean SBP levels in the TT groups vs CC groups were 129.0 vs 127.5 mmHg (p=0.41) for total subjects, 131.1 vs 127.9 mmHg (p=0.15) for subjects with lower sodium excretion, 130.8 vs 128.7 mmHg (p=0.44) for subjects with lower present sodium intake score, and 130.8 vs 127.2 mmHg (p=0.13) for subjects with lower past sodium intake score (data not shown in the tables). The mean BP levels were higher in subjects on medication use than those without medication; age-adjusted mean SBPs were 139.9 mmHg in those with medication vs 129.0 mmHg in those without medication (p<0.0001), and respective DBP were 81.9 mmHg vs 77.8 mmHg (p<0.0001) (data not shown in the tables). The distribution of genotypes was similar between subjects with and without antihypertensive medication; the distributions of CC, CT and TT genotype were 26%, 51% and 22% for subjects with medication, and 23%, 50%, and 27% for subjects without medication (p for chi-square test = 0.19). In a previous study, we showed that high sodium intake strengthened the gene-blood pressure associations for angiotensinogen (AGT) T174M ) and α-adducin (ADD1) G460W polymorphisms . In contrast, in the present study, the GNB3-systolic blood pressure association was more evident among subjects with lower sodium intake/excretion, but not with higher intake/excretion.
This result was unexpected, but it is possible that high salt intake masks the potential effect of GNB3 on blood pressure levels. Our finding helps to explain the inconsistency of the reported genetic associations: positive associations in the majority of studies in whites (Siffert, 2003) , but no associations in the majority of studies of Japanese (Kato et al, 1998; Kario et al, 1999; Ishikawa et al, 2000; Tozawa, 2001; Suwazono et al, 2004; Shioji et al, 2004) , African-American (Larson et al ,2000) , Chinese (Huang et al , 2003; Li et al, 2005) , Taiwanese (Tsai et al, 2000) , and Kazakh in China (Wang et al, 2004 ). This ethnic difference may be explained in part by differences in salt intake, which is higher in Asian and African-American populations than in whites (Intersalt Cooperative Research Group, 1988) .
The GNB3 C825T polymorphism has been suspected to be a genetic marker of salt-sensitive hypertension (Beeks et al, 2004 . Other studies showed significant relations among GNB3 genotype and low plasma renin activity (Schunkert et al, 1998) , high response Yamagishi et al., Page 12 to diuretics (Turner et al, 2001) , left ventricular hypertrophy (Poch et al, 2000; Semplicini et al, 2001 ) and renal plasma flow (Zeltner et al, 2001) , which support the above hypothesis. However, it is still uncertain whether the C825T polymorphism affects Na + /H + exchanger since two experimental studies showed no association between C825T polymorphism and salt-sensitivity (Schorr et al, 2000; Pamies-Andreu et al, 2003) . Also in the present study, sodium did not strengthen the associations of GNB3 with BP levels, which is in contradiction to our a priori hypothesis. In the present study, approximately 20% of the participating individuals used antihypertensive medication, which may have obscured the genetic effect of BP levels.
When we excluded individuals with antihypertensive medication from the analysis, the gene-BP association became weaker. Weakening of the association may be caused by the smaller variation of BP levels after the exclusion of subjects with high BP levels. In fact, the mean BP levels were higher in subjects on medication use than those without medication.
The strength of the present study was that we used a large community-based free-living population. In addition, we obtained 24-h urine collection samples and sodium intake scores, which allowed us to test gene-environmental interactions of the GNB3 C825T genotype with BP levels in a general population. Previously, two experimental studies with smaller numbers of subjects (Schorr et al, 2000; Pamies-Andreu et al, 2003) examined the relation between C825T genotype and dietary salt or salt sensitivity, with negative results. However, to our knowledge, the Yamagishi et al., Page 13 present study is the first report that evaluated the gene-environmental interaction of GNB3 polymorphism, sodium, and BP in a large free-living general population. The limitations of the present study warrant discussion. Firstly, we did not have information about the antihypertensive agents used by the population tested. The use of hydrochlorothiazide or clonidine was reported to reduce SBP levels more in subjects with TT genotype than in those with CC genotype (Turner et al, 2001; Nürnberger et al, 2003) . However, in this community, it is our impression that the majority of hypertensive patients were treated primarily by calcium channel blockers, like in other communities of Japan. Long-term use of calcium blockers is unlikely to change sodium excretion or sodium retention (Leonetti, 1994) . Secondly, the gene-BP association was primarily obtained for women only, although the interaction of sex in relation to the genotype with BP levels was not statistically significant (p for sex-interaction = 0.94 for SBP). A probable reason for the relatively weak association in men was the smaller number of men than women. Thirdly, the variation of sodium excretion by one 24-h urine sample may be very large and the possibility of misclassification between low and high sodium excretion groups could be real.
However, since the study included a large sample size, the impact of misclassification across the stratification is probably small. In the present study, 66% of persons remained in the same group of higher or lower sodium intake after one-year re-collection of urinary sodium excretion in the sub-sample group. Lastly, in Table 3, blood pressure levels were sometimes lower in groups with higher sodium excretion or intake than lower ones with the same genotypes, which was also observed in Japanese populations according to the Intersalt study (Intersalt Cooperative Research Yamagishi et al., Page 14 Group, 1988) . A plausible reason for this phenomenon is that most of the hypertensives attempted to reduce salt intake when they recognized their blood pressure levels were high, since salt reduction is well known to reduce blood pressure in the Japanese society.
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In conclusion, the GNB3 C825T polymorphism tends to be associated with SBP levels in Japanese population. This association was more specifically observed among women with a low sodium excretion against our a priori hypothesis. This finding, however, helps to explain part of the discrepancy of the reported genetic association among different ethnic groups. Blood pressure values were adjusted for sex, age, antihypertensive medication use, body mass index and alcohol consumption.
Tests for difference from CC genotype were conducted using Dunnett's multiple comparison method. Yamagishi et al., Page 3 415 conducted using Dunnett's multiple comparison method. Median values of urinary sodium excretion are 169.9 mmol/day for women and 185.2 mmol/day for men, 5 for present sodium intake score in women and 6 in men, and 6 for past sodium intake score in women and 7 in men.
